Log in
Enquire now
‌

US Patent 7371826 Polypeptide variants with altered effector function

Patent 7371826 was granted and assigned to Genentech on May, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Date Filed
May 8, 2006
0
Date of Patent
May 13, 2008
0
Patent Application Number
11429793
0
Patent Citations Received
‌
US Patent 12134649 Anti-B7-H4 antibodies and immunoconjugates
0
‌
US Patent 12110339 ICOS ligand variant immunomodulatory proteins and uses thereof
0
‌
US Patent 12116414 Method of modifying isoelectric point of antibody via amino acid substitution in CDR
0
‌
US Patent 12122840 Method of modifying isoelectric point of antibody via amino acid substitution in CDR
0
‌
US Patent 12128101 Dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)
0
‌
US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors
0
‌
US Patent 11753458 CTLA-4 variant immunomodulatory proteins and uses thereof
‌
US Patent 11760801 Anti-CEACAM antibodies and uses thereof
‌
US Patent 11771698 Methods of treating cholangiocarcinoma
‌
US Patent 11774452 Antibodies against carcinoembryonic antigens
•••
Patent Inventor Names
Leonard Presta
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7371826
0
Patent Primary Examiner
‌
Maher M. Haddad
0

Find more entities like US Patent 7371826 Polypeptide variants with altered effector function

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us